The InsHeal Content Repository contains a large number of articles on anti-diabetes medications, some examples are given below. For details and sample articles, please write to us at: insheal@insiwi.in.
| Acarbose | Acarbose is an oral tablet that reduces the absorption of carbohydrates from the digestive tract into the blood, and therefore reduces the blood glucose levels in patients with type 2 diabetes. | |
| Alogliptin | Alogliptin is an anti-diabetes drug that belongs to a group called dipeptidyl peptidase IV (DPP IV) inhibitors. It increases the levels of certain hormones that reduce blood glucose and therefore helps to control blood glucose levels in patients with type 2 diabetes. It should not be used in patients with severe liver disease. | |
| Canagliflozin | Canagliflozin is an anti-diabetes drug that increases the loss of glucose through the urine. It belongs to a group of drugs called the SGLT2 (sodium-glucose transporter 2) inhibitors. It also reduces the blood pressure and improves the level of HDL-cholesterol in diabetes patients. | |
| Dapagliflozin | Dapagliflozin is an anti-diabetes drug that increases the loss of glucose through the urine. It belongs to a group of drugs called the SGLT2 (sodium-glucose transporter 2) inhibitors. It is also useful in certain heart failure patients. It can be used to treat certain cases of chronic kidney disease irrespective of the presence of diabetes. | |
| Dulaglutide | Dulaglutide is a non-insulin injection used once a week to treat diabetes along with other anti-diabetes medications. It belongs to a group of drugs called GLP-1 receptor agonists. | |
| Empagliflozin | Empagliflozin is an anti-diabetes drug that increases the loss of glucose through the urine. It belongs to a group of drugs called the SGLT2 (sodium-glucose transporter 2) inhibitors. | |
| Exenatide | Exenatide is a non-insulin injection used to treat diabetes along with other medications. It belongs to a group of drugs called GLP-1 receptor agonists. It must be injected twice a day. | |
| Gemigliptin | Gemigliptin is an anti-diabetes drug that belongs to a group called dipeptidyl peptidase IV (DPP IV) inhibitors. It increases the levels of certain hormones that reduce blood glucose and therefore helps to control blood glucose levels in patients with type 2 diabetes. | |
| Glimepiride | Glimepiride is an anti-diabetes tablet used to reduce blood sugar levels in patients with type 2 diabetes. It should be used with caution in the elderly, and patients with liver or kidney disease. It is taken once a day. | |
| Glipizide | Glipizide is an anti-diabetes tablet used to reduce blood sugar levels in patients with type 2 diabetes. It stimulates the release of insulin by the pancreas. Doses above 15 mg per day are administered twice a day. An extended release form of the tablet is also available, which is administered once a day. | |
| Insulin aspart | Insulin aspart is a form of insulin that acts very rapidly once it is injected just below the skin. | |
| Insulin aspart plus insulin aspart protamine | This injection contains both, the rapidly acting insulin aspart, and insulin aspart protamine, whose effect can last for up to 24 hours. | |
| Insulin glulisine | Insulin glulisine is a form of insulin that acts very rapidly once it is injected just below the skin. The injection is administered close to a meal to handle the high glucose levels following a meal. | |
| Insulin lispro | Insulin lispro is a form of insulin that acts very rapidly once it is injected just below the skin. The injection is administered close to a meal to handle the high glucose levels following a meal. | |
| Insulin lispro plus insulin lispro protamine | This injection contains insulin lispro, which acts rapidly following administration, and insulin lispro protamine, the effect of which lasts for 24 hours. It can be administered twice a day, before a meal. | |
| Regular insulin / soluble insulin | Regular insulin, also called soluble insulin, is a fairly quick acting insulin. Its The effect in lowering blood glucose level begins within 15 to 30 minutes following the injection. | |
| NPH insulin /isophane insulin | NPH insulin, also called isophane insulin, is a intermediate-acting form of insulin. It takes 1 to 2 hours to being its effect after the it is injected just below the skin. Its effect lasts for 14 to 24 hours after the injection. | |
| Regular insulin plus NPH Insulin | The combination of regular and NPH insulin begins its effect around 15 to 30 minutes following the injection and the effect lasts for between 14 to 24 hours. | |
| Insulin degludec | Insulin degludec is a long-acting form of insulin. Its effect begins in 30-90 minutes following the injection and may last for more than 42 hours. It is used to maintain the basal insulin levels in diabetes patients. | |
| Insulin aspart plus insulin degludec | This combination combines the rapid acting insulin aspart and the long-acting insulin degludec, providing an immediate as well as a prolonged effect. | |
| Insulin detemir | Insulin detemir is a long-acting form of insulin. Its effect begins in 3 to 4 hours following the injection and may last for 6 to 23 hours depending on the dose. It is used to maintain the basal insulin levels in patients with type 1 diabetes and some type 2 diabetes patients. | |
| Insulin glargine | Insulin glargine is a long-acting form of insulin. Its effect begins in 3 to 6 hours after the injection and lasts for around 24 hours. | |
| Linagliptin | Linagliptin is an oral tablet that is used to treat certain cases of type 2 diabetes. It belongs to a group of medications called dipeptidyl peptidase IV (DPP IV) inhibitors. It increases the levels of certain hormones in the body that help to control the blood glucose levels. | |
| Liraglutide | Liraglutide is a non-insulin injection used once a day to treat diabetes. It belongs to a group of drugs called GLP-1 receptor agonists and is used along with other anti-diabetes medications. It is also approved as a weight-loss treatment for select cases. | |
| Lixisenatide | Lixisenatide is a non-insulin injection that belongs to a group of drugs called GLP-1 receptor agonists. It is used along with other anti-diabetes medications to treat type 2 diabetes. | |
| Metformin | Metformin is an age-old and time-tested oral medicine used to treat diabetes. It is also used to treat polycystic ovarian disease. | |
| Miglitol | Miglitol is an oral tablet that reduces the absorption of carbohydrates from the digestive tract into the blood, and therefore reduces the blood glucose levels in patients with type 2 diabetes. | |
| Nateglinide | Nateglinide is a tablet that stimulates the release of insulin from the pancreas, and therefore helps to control the blood glucose levels. It should be avoided or used with caution in people with liver disease. | |
| Pioglitazone | Pioglitazone is an oral anti-diabetes tablet that increases the sensitivity of the tissues of the body to insulin. It could affect the liver, and therefore tests to check the liver function should be done regularly while the patient takes pioglitazone. | |
| Repaglinide | Repaglinide stimulates the release of insulin from the pancreas, and therefore helps to control the blood glucose levels. | |
| Saxagliptin | Saxagliptin is an oral tablet that is used to treat certain cases of type 2 diabetes. It belongs to a group of medications called dipeptidyl peptidase IV (DPP IV) inhibitors. It increases the levels of certain hormones in the body that help to control blood glucose levels. | |
| Sitagliptin | Saxagliptin is an oral tablet that is used to treat certain cases of type 2 diabetes. It belongs to a group of medications called dipeptidyl peptidase IV (DPP IV) inhibitors. It increases the levels of certain hormones in the body that help to control blood glucose levels. It should be used with caution in people with liver or kidney disease. | |
| Vildagliptin | Vildagliptin is an oral tablet that is used to treat certain cases of type 2 diabetes. It belongs to a group of medications called dipeptidyl peptidase IV (DPP IV) inhibitors. It increases the levels of certain hormones in the body that help to control blood glucose levels. | |
| Voglibose | Voglibose acts on the digestive tract to reduce the absorption of glucose into the blood, thereby reducing blood glucose levels. It is often used along with other antidiabetes medications to control the blood glucose levels in patients with type 2 diabetes. |
Disclaimer: The information provided on this site is not intended to replace the relationship between the doctor and the patient. It should not be used for self-treatment by patients or by doctors to treat patients. Consult your doctor before using any of the above information.
Insights on Health and Wellness 